T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity

Thyroxine (T4)+triiodothyronine (T3) combination therapy can be considered in case of persistent symptoms despite normal serum thyroid stimulating hormone in levothyroxine (LT4)-treated hypothyroid patients. Combination therapy has gained popularity in the last two decades, especially in countries w...

Descripción completa

Detalles Bibliográficos
Autor principal: Wiersinga, Wilmar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566135/
https://www.ncbi.nlm.nih.gov/pubmed/34587734
http://dx.doi.org/10.3803/EnM.2021.501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566135/
https://www.ncbi.nlm.nih.gov/pubmed/34587734
http://dx.doi.org/10.3803/EnM.2021.501

Ejemplares similares